Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
11,964 Cardiology
clinical trials

Symptomatic Neurogenic Orthostatic Hypotension Clinical Trial
Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Status: Enrolling, Phase IV
Updated: 9/14/2017
Northwestern Medical Group
mi
from
Chicago, IL
Click here to add this to my saved trials
Symptomatic Neurogenic Orthostatic Hypotension Clinical Trial
Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Status: Enrolling, Phase IV
Updated: 9/14/2017
David L. Kreitzman, MD, P.C.
mi
from
Commack, NY
Click here to add this to my saved trials
Symptomatic Neurogenic Orthostatic Hypotension Clinical Trial
Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Status: Enrolling, Phase IV
Updated: 9/14/2017
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Raynaud's Disease Clinical Trial
Diosmiplex (Vasculera®) in Primary and Secondary Raynaud's Phenomenon
Status: Enrolling
Updated: 2/16/2016
Sun Valley Arthritis Center, Ltd
mi
from
Peoria, AZ
Click here to add this to my saved trials
Transthyretin (TTR) Amyloid Cardiomyopathy Clinical Trial
Long-term Safety of Tafamidis in Subjects With Transthyretin Cardiomyopathy
Status: Enrolling, Phase III
Updated: 12/31/1969
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Transthyretin (TTR) Amyloid Cardiomyopathy Clinical Trial
Long-term Safety of Tafamidis in Subjects With Transthyretin Cardiomyopathy
Status: Enrolling, Phase III
Updated: 12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Transthyretin (TTR) Amyloid Cardiomyopathy Clinical Trial
Long-term Safety of Tafamidis in Subjects With Transthyretin Cardiomyopathy
Status: Enrolling, Phase III
Updated: 12/31/1969
Newark Beth Israel Medical Center
mi
from
Newark, NJ
Click here to add this to my saved trials
Transthyretin (TTR) Amyloid Cardiomyopathy Clinical Trial
Long-term Safety of Tafamidis in Subjects With Transthyretin Cardiomyopathy
Status: Enrolling, Phase III
Updated: 12/31/1969
Advocate Christ Medical Center
mi
from
Oak Lawn, IL
Click here to add this to my saved trials
Transthyretin (TTR) Amyloid Cardiomyopathy Clinical Trial
Long-term Safety of Tafamidis in Subjects With Transthyretin Cardiomyopathy
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Utah Medical Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Transthyretin (TTR) Amyloid Cardiomyopathy Clinical Trial
Long-term Safety of Tafamidis in Subjects With Transthyretin Cardiomyopathy
Status: Enrolling, Phase III
Updated: 12/31/1969
University of California
mi
from
San Francisco, CA
Click here to add this to my saved trials
Transthyretin (TTR) Amyloid Cardiomyopathy Clinical Trial
Long-term Safety of Tafamidis in Subjects With Transthyretin Cardiomyopathy
Status: Enrolling, Phase III
Updated: 12/31/1969
UCSF Cardiovascular Care and Prevention Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Educational Videos to Address Racial Disparities in Implantable Cardioverter Defibrillator Therapy
Status: Enrolling
Updated: 12/31/1969
Rutgers Robert Wood Johnson Medical School
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Chronic Heart Failure (CHF) Clinical Trial
Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis
mi
from
Baltimore, MD
Click here to add this to my saved trials
Chronic Heart Failure (CHF) Clinical Trial
Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigator Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
Chronic Heart Failure (CHF) Clinical Trial
Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Bronx, NY
Click here to add this to my saved trials
Chronic Heart Failure (CHF) Clinical Trial
Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Elmer, NJ
Click here to add this to my saved trials
Chronic Heart Failure (CHF) Clinical Trial
Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Eunice, LA
Click here to add this to my saved trials
Chronic Heart Failure (CHF) Clinical Trial
Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Everett, WA
Click here to add this to my saved trials
Chronic Heart Failure (CHF) Clinical Trial
Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Gastonia, NC
Click here to add this to my saved trials
Chronic Heart Failure (CHF) Clinical Trial
Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Hollywood, FL
Click here to add this to my saved trials
Chronic Heart Failure (CHF) Clinical Trial
Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Chronic Heart Failure (CHF) Clinical Trial
Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Chronic Heart Failure (CHF) Clinical Trial
Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Lombard, IL
Click here to add this to my saved trials
Chronic Heart Failure (CHF) Clinical Trial
Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Long Beach, CA
Click here to add this to my saved trials
Chronic Heart Failure (CHF) Clinical Trial
Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Lufkin, TX
Click here to add this to my saved trials
Chronic Heart Failure (CHF) Clinical Trial
Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction
Status: Enrolling, Phase III
Updated: 12/31/1969
319, Novartis Investigational Site
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
Chronic Heart Failure (CHF) Clinical Trial
Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Naples, FL
Click here to add this to my saved trials
Chronic Heart Failure (CHF) Clinical Trial
Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Oregon City, OR
Click here to add this to my saved trials
Chronic Heart Failure (CHF) Clinical Trial
Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative site
mi
from
Providence, RI
Click here to add this to my saved trials
Chronic Heart Failure (CHF) Clinical Trial
Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
South Miami, FL
Click here to add this to my saved trials
Chronic Heart Failure (CHF) Clinical Trial
Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Southfield, MI
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
Pulmonary Vascular Disease Phenomics Program PVDOMICS
Status: Enrolling, Phase
Updated: 12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
Pulmonary Vascular Disease Phenomics Program PVDOMICS
Status: Enrolling, Phase
Updated: 12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
Status: Enrolling
Updated: 12/31/1969
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
Status: Enrolling
Updated: 12/31/1969
Community Hospital of Anaconda
mi
from
Anaconda, MT
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
Status: Enrolling
Updated: 12/31/1969
Mission Hospital-Memorial Campus
mi
from
Asheville, NC
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
Status: Enrolling
Updated: 12/31/1969
MultiCare Regional Cancer Center--Auburn
mi
from
Auburn, WA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
Status: Enrolling
Updated: 12/31/1969
Veterans Administration/Harry S Truman Memorial Hospital
mi
from
Columbia, MO
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
Status: Enrolling
Updated: 12/31/1969
Henry Ford Health System
mi
from
Detroit, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
Status: Enrolling
Updated: 12/31/1969
Benefis Sletten Cancer Institute
mi
from
Great Falls, MT
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
Status: Enrolling
Updated: 12/31/1969
East Carolina University
mi
from
Greenville, NC
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
Status: Enrolling
Updated: 12/31/1969
Memorial Regional Hospital
mi
from
Hollywood, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
Status: Enrolling
Updated: 12/31/1969
Dana-Farber/New Hampshire Oncology-Hematology
mi
from
Londonderry, NH
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
Status: Enrolling
Updated: 12/31/1969
James Graham Brown Cancer Center
mi
from
Louisville, KY
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
Status: Enrolling
Updated: 12/31/1969
University of Louisville, Division of Surgical Oncology
mi
from
Louisville, KY
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
Status: Enrolling
Updated: 12/31/1969
Middlesex Hospital
mi
from
Middletown, CT
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
Status: Enrolling
Updated: 12/31/1969
South Shore Hospital
mi
from
South Weymouth, MA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
Status: Enrolling
Updated: 12/31/1969
Toledo Clinic Cancer Center-Toledo
mi
from
Toledo, OH
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
Status: Enrolling
Updated: 12/31/1969
Dayton Physicians LLC-Upper Valley
mi
from
Troy, OH
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)
Status: Enrolling, Phase III
Updated: 12/31/1969
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)
Status: Enrolling, Phase III
Updated: 12/31/1969
Banner University Medical Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
Thrombosis Clinical Trial
Pharmacokinetic, Pharmacodynamic, Safety, and Efficacy Study of Rivaroxaban for Thromboprophylaxis in Pediatric Participants 2 to 8 Years of Age After the Fontan Procedure
Status: Enrolling, Phase III
Updated: 12/31/1969
Penn State Hershey Children's Hospital
mi
from
Hershey, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Orthopedics / Podiatry, Other Clinical Trial
Treatment of Post-SCI Hypotension
Status: Enrolling, Phase II, III
Updated: 12/31/1969
VA Medical Center, Bronx
mi
from
Bronx, NY
Click here to add this to my saved trials
Coronary Artery Disease Clinical Trial
IU Health Krannert Personalized Medicine Study
Status: Enrolling, Phase IV
Updated: 1/22/2018
Indiana University Health Methodist Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta (Zone 0/1)
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta (Zone 0/1)
Status: Enrolling
Updated: 12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta (Zone 0/1)
Status: Enrolling
Updated: 12/31/1969
Houston Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta (Zone 0/1)
Status: Enrolling
Updated: 12/31/1969
St. Vincent Medical Group
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta (Zone 0/1)
Status: Enrolling
Updated: 12/31/1969
Arizona Heart Institute
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta (Zone 0/1)
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta (Zone 2)
Status: Enrolling
Updated: 12/31/1969
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta (Zone 2)
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta (Zone 2)
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta (Zone 2)
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta (Zone 2)
Status: Enrolling
Updated: 12/31/1969
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta (Zone 2)
Status: Enrolling
Updated: 12/31/1969
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta (Zone 2)
Status: Enrolling
Updated: 12/31/1969
Univeristy of South Florida
mi
from
Tampa, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta (Zone 2)
Status: Enrolling
Updated: 12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases Clinical Trial
Hepatitis C Virus(HCV) Heart and Lung Study
Status: Enrolling, Phase IV
Updated: 12/31/1969
Henry Ford Health System
mi
from
Detroit, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
A Randomized Multicenter Study for Isolated Skin Vasculitis
Status: Enrolling, Phase II
Updated: 12/31/1969
Boston University School of Medicine
mi
from
Boston, MA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
A Randomized Multicenter Study for Isolated Skin Vasculitis
Status: Enrolling, Phase II
Updated: 12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Myocardial Infarction Clinical Trial
Women's Heart Attack Research Program: Stress Ancillary Study
Status: Enrolling
Updated: 12/31/1969
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Thrombosis Clinical Trial
A Study of the Safety and Pharmacokinetics of Apixaban Versus Vitamin K Antagonist (VKA) or Low Molecular Weight Heparin (LMWH) in Pediatric Subjects With Congenital or Acquired Heart Disease Requiring Anticoagulation
Status: Enrolling, Phase II
Updated: 12/31/1969
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Thrombosis Clinical Trial
A Study of the Safety and Pharmacokinetics of Apixaban Versus Vitamin K Antagonist (VKA) or Low Molecular Weight Heparin (LMWH) in Pediatric Subjects With Congenital or Acquired Heart Disease Requiring Anticoagulation
Status: Enrolling, Phase II
Updated: 12/31/1969
Children's Healthcare of Atlanta
mi
from
Atlanta, GA
Click here to add this to my saved trials
Thrombosis Clinical Trial
A Study of the Safety and Pharmacokinetics of Apixaban Versus Vitamin K Antagonist (VKA) or Low Molecular Weight Heparin (LMWH) in Pediatric Subjects With Congenital or Acquired Heart Disease Requiring Anticoagulation
Status: Enrolling, Phase II
Updated: 12/31/1969
The University of California, San Diego
mi
from
La Jolla, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Nephrology / Urology Clinical Trial
Safety and Efficacy of ANX-042 in Human Cardiorenal Syndrome
Status: Enrolling, Phase I
Updated: 12/31/1969
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Carotid Artery Stenosis Clinical Trial
Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis
Status: Enrolling
Updated: 12/31/1969
University at Buffalo
mi
from
Buffalo, NY
Click here to add this to my saved trials
Carotid Artery Stenosis Clinical Trial
Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis
Status: Enrolling
Updated: 12/31/1969
Wellmont CVA Heart Institute
mi
from
Kingsport, TN
Click here to add this to my saved trials
Carotid Artery Stenosis Clinical Trial
Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis
Status: Enrolling
Updated: 12/31/1969
St. Luke's Medical Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Carotid Artery Stenosis Clinical Trial
Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis
Status: Enrolling
Updated: 12/31/1969
Stony Brook University Medical Center
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Carotid Artery Stenosis Clinical Trial
Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis
Status: Enrolling
Updated: 12/31/1969
Berks Cardiologists
mi
from
Wyomissing, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Radiation-Free Heart Catheterization Using MRI
Status: Enrolling, Phase I
Updated: 12/31/1969
Children's National Health System
mi
from
Washington DC,
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology, Neurology, Psychiatry / Psychology Clinical Trial
Aneurysmal Subarachnoid Hemorrhage Trial RandOmizing Heparin
Status: Enrolling, Phase II
Updated: 10/23/2017
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology, Neurology, Psychiatry / Psychology Clinical Trial
Aneurysmal Subarachnoid Hemorrhage Trial RandOmizing Heparin
Status: Enrolling, Phase II
Updated: 10/23/2017
University of Louisville
mi
from
Louisville, KY
Click here to add this to my saved trials
Aortic Stenosis Clinical Trial
The PARTNER 3 - Trial - The Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis
Status: Enrolling, Phase III
Updated: 12/31/1969
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Aortic Stenosis Clinical Trial
The PARTNER 3 - Trial - The Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis
Status: Enrolling, Phase III
Updated: 12/31/1969
Hartford
mi
from
Hartford, CT
Click here to add this to my saved trials
Aortic Stenosis Clinical Trial
The PARTNER 3 - Trial - The Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
Aortic Stenosis Clinical Trial
The PARTNER 3 - Trial - The Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis
Status: Enrolling, Phase III
Updated: 12/31/1969
Cornell University
mi
from
New York, NY
Click here to add this to my saved trials
Aortic Stenosis Clinical Trial
The PARTNER 3 - Trial - The Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis
Status: Enrolling, Phase III
Updated: 12/31/1969
NYU Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Aortic Stenosis Clinical Trial
The PARTNER 3 - Trial - The Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis
Status: Enrolling, Phase III
Updated: 12/31/1969
Columbia University Medical Center and the New York Presbyterian Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Aortic Stenosis Clinical Trial
The PARTNER 3 - Trial - The Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis
Status: Enrolling, Phase III
Updated: 12/31/1969
Banner University Medical Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Aortic Stenosis Clinical Trial
The PARTNER 3 - Trial - The Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis
Status: Enrolling, Phase III
Updated: 12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Influence of Myocardial Shortening on Coronary Tortuosity
Status: Enrolling
Updated: 4/16/2016
OHSU
mi
from
Portland, OR
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure
Status: Enrolling, Phase IV
Updated: 12/31/1969
Univ of Hawaii
mi
from
Honolulu, HI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure
Status: Enrolling, Phase IV
Updated: 12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure
Status: Enrolling, Phase IV
Updated: 12/31/1969
Albany Medical College
mi
from
Albany, NY
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure
Status: Enrolling, Phase IV
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure
Status: Enrolling, Phase IV
Updated: 12/31/1969
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure
Status: Enrolling, Phase IV
Updated: 12/31/1969
Pentucket Medical Associates
mi
from
Haverhill, MA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure
Status: Enrolling, Phase IV
Updated: 12/31/1969
Gundersen Clinic, Ltd.
mi
from
La Crosse, WI
Click here to add this to my saved trials
1 … 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 … 120